These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 19179632)
21. Requirements for FDA-approved patient information spelled out in final rule. Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523 [No Abstract] [Full Text] [Related]
22. Patient information leaflets in surgical practice: a contemporary review. Shrestha BM JNMA J Nepal Med Assoc; 2007; 46(166):84-9. PubMed ID: 18094744 [TBL] [Abstract][Full Text] [Related]
23. Some patients may receive too much information about prescriptions. Lavine G Am J Health Syst Pharm; 2009 Apr; 66(8):696-7. PubMed ID: 19336824 [No Abstract] [Full Text] [Related]
24. Suitability and readability of consumer medical information accompanying prescription medication samples. Wallace LS; Keenum AJ; Roskos SE; Blake GH; Colwell ST; Weiss BD Patient Educ Couns; 2008 Mar; 70(3):420-5. PubMed ID: 18178363 [TBL] [Abstract][Full Text] [Related]
25. Find out about the side effects of your prescription drugs. Here's how to locate the information--and how to make sense of what you find. Harv Health Lett; 2005 Apr; 30(6):1-3. PubMed ID: 15844241 [No Abstract] [Full Text] [Related]
27. Food and Drug Administration labeling and medication guides: A health outcomes critique. Watterson TL Res Social Adm Pharm; 2019 Sep; 15(9):1191-1192. PubMed ID: 31003764 [No Abstract] [Full Text] [Related]
28. Education becomes focus of classwide opioid REMS. Thompson CA Am J Health Syst Pharm; 2012 Aug; 69(16):1352. PubMed ID: 22855094 [No Abstract] [Full Text] [Related]
29. Patient information leaflets for anaesthetic drugs. Paoloni CC; Arrowsmith JE Anaesthesia; 2000 Sep; 55(9):911. PubMed ID: 10991752 [No Abstract] [Full Text] [Related]
30. Characteristics of container labeling in a sample of commonly prescribed children's oral medications. Wallace LS; Keenum AJ; DeVoe JE Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385 [TBL] [Abstract][Full Text] [Related]
31. US FDA patient-reported outcome guidance: great expectations and unintended consequences. Fehnel S; DeMuro C; McLeod L; Coon C; Gnanasakthy A Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):441-6. PubMed ID: 23977972 [TBL] [Abstract][Full Text] [Related]
32. Regulatory agencies' recommendations for medicine information leaflets: Are they in line with research findings? Young A; Tordoff J; Smith A Res Social Adm Pharm; 2018 Feb; 14(2):196-202. PubMed ID: 28285793 [TBL] [Abstract][Full Text] [Related]
33. FDA chief says demand by patients for more drug information is genuine. Health Educ Rep; 1980 Jul; 2(15):4-5. PubMed ID: 10247629 [No Abstract] [Full Text] [Related]
35. Providing patients with written medication information. Buck ML Ann Pharmacother; 1998 Sep; 32(9):962-9. PubMed ID: 9762384 [TBL] [Abstract][Full Text] [Related]
36. Patient package inserts: the proper prescription? Rowe HM Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988 [No Abstract] [Full Text] [Related]
37. Patient information leaflets: "a stupid system". McCartney M BMJ; 2013 Jul; 347():f4748. PubMed ID: 23900316 [No Abstract] [Full Text] [Related]
38. FDA proposes patient package inserts for most drugs. Mayberger HW; Bell BJ Leg Aspects Med Pract; 1979 Oct; 7(10):42-4. PubMed ID: 263192 [No Abstract] [Full Text] [Related]